Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-25-007780
Filing Date
2025-03-10
Accepted
2025-03-10 09:19:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 21417
2 EXHIBIT 4 ef20045145_ex4.htm EX-4 16642
  Complete submission text file 0001140361-25-007780.txt   39954
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91734 | Film No.: 25722378
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 171 MAIN STREET SUITE 259 LOS ALTOS CA 94022
Business Address 171 MAIN STREET SUITE 259 LOS ALTOS CA 94022 650-209-9500
ABeeC 2.0, LLC (Filed by) CIK: 0001869643 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13D/A